Evidence map›Paper›PMID 37563802›Full record

ArticleThe Journal of antimicrobial chemotherapy2023

Evaluation of the RESIST ACINETO multiplex immunochromatographic assay for detection of OXA-23-like, OXA-40/58-like and NDM carbapenemase production in Acinetobacter baumannii.

Stefano Mancini, Helena M B Seth-Smith, Natalia Kolesnik-Goldmann, Vladimira Hinic, Tim Roloff, Frank Imkamp, Adrian Egli

Open access · hybridAbstract readLetter
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Membrane-Focused Strategies AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  3. Detection of OXA-23 and OXA-58 inMicrobiology spectrum · 2026
    Article
  4. Review
  5. Turning the Tide Against Carbapenem-resistantOpen forum infectious diseases · 2025
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stefano ManciniInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Helena M B Seth-SmithInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Natalia Kolesnik-GoldmannInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Vladimira HinicInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Tim RoloffInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Frank ImkampInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.
Adrian EgliInstitute of Medical Microbiology, University Zurich, Gloriastrasse 28/30, 8006 Zurich, Switzerland.ORCID 0000-0002-3564-8603
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID37563802
PMCPMC10631821
OpenAlexW4385751512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.